These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29152661)

  • 1. Apolipoprotein status in type 2 diabetes mellitus and its complications (Review).
    Zhang P; Gao J; Pu C; Zhang Y
    Mol Med Rep; 2017 Dec; 16(6):9279-9286. PubMed ID: 29152661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns.
    Katulanda GW; Katulanda P; Adler AI; Peiris SR; Draisey I; Wijeratne S; Sheriff R; Matthews DR; Shine B
    Ann Clin Biochem; 2010 Jan; 47(Pt 1):29-34. PubMed ID: 19952033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
    Raj R; Bhatti JS; Badada SK; Ramteke PW
    Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Tao Q; Zhang Y
    Lipids Health Dis; 2016 Sep; 15(1):158. PubMed ID: 27633510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
    Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
    Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
    Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
    Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.
    Zhang PH; Gao JL; Pu C; Feng G; Wang LZ; Huang LZ; Zhang Y
    Lipids Health Dis; 2016 Aug; 15(1):142. PubMed ID: 27576735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
    El-Lebedy D; Raslan HM; Mohammed AM
    Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
    Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of Diabetic Dyslipidaemia.
    Filippatos T; Tsimihodimos V; Pappa E; Elisaf M
    Curr Vasc Pharmacol; 2017; 15(6):566-575. PubMed ID: 28155609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
    Pechlaner R; Tsimikas S; Yin X; Willeit P; Baig F; Santer P; Oberhollenzer F; Egger G; Witztum JL; Alexander VJ; Willeit J; Kiechl S; Mayr M
    J Am Coll Cardiol; 2017 Feb; 69(7):789-800. PubMed ID: 28209220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Plasma ApoE Levels are Associated with Low-Normal Thyroid Function: Studies in Diabetic and Nondiabetic Subjects.
    van Tienhoven-Wind LJ; Dallinga-Thie GM; Dullaart RP
    Horm Metab Res; 2016 Jul; 48(7):462-7. PubMed ID: 26916531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol.
    Savinova OV; Fillaus K; Harris WS; Shearer GC
    Atherosclerosis; 2015 Jun; 240(2):520-5. PubMed ID: 25932792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
    Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
    Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study.
    Brahimaj A; Ligthart S; Ikram MA; Hofman A; Franco OH; Sijbrands EJ; Kavousi M; Dehghan A
    Diabetes Care; 2017 Mar; 40(3):346-351. PubMed ID: 28031419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.